pigment epithelium-derived factor. VEGF. vascular endothelial growth factor. Linked Articles. *BJO at a glance. BJO at a glance ...

Anti-Vascular endothelial growth factor treatment for diabetic macular edema in a real-world clinical setting. Am J Ophthalmol ... In recent years, the treatment of DMO has changed greatly with the advent of antivascular endothelial growth factor (VEGF) ... Real-world outcomes of anti-vascular endothelial growth factor therapy in diabetic macular edema in the United States. ... As interventions, antivascular endothelial growth factor (VEGF) agents, local corticosteroids, macular photocoagulation and ...

1996) Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in ... 1997) Regulation of endothelin converting enzyme 1 mRNA expression by vascular endothelial growth factor (ARVO Abstracts). ... Long lasting hypoxia can induce upregulation of vascular endothelial growth factor (VEGF) receptors, VEGF overexpression, and ... and vascular endothelial growth factor (VEGF) during retinal neovascularization. Invest Ophthalmol Vis Sci 39(4 suppl):S517. ...

Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: Two-year outcomes. ... Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal ... The rationale for use of an intravitreally injected antivascular endothelial growth factor (VEGF) drug to treat BRVO is that ... Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor ...

Vascular endothelial growth factor inhibitors (anti-VEGF) in the management of diabetic macular oedema: a systematic review ... Vascular endothelial growth factor inhibitors (anti-VEGF) in the management of diabetic macular oedema: a systematic review ... Background and research question The authors address the question of whether vascular endothelial growth factor inhibitors ( ...

Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly ... Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly ... The treatment group received a vascular endothelial growth factor-A specific cytokine trap (VEGF Trap) intraperitoneally at ...

Altering the clinical course of Sorsby fundus dystrophy with the use of anti-vascular endothelial growth factor intraocular ... suggesting that other important factors influence phenotype, including genetic modifiers and the environment.6-8 ...

Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight ... Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight ... Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight ...

Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for ... Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for ... and long-term blockade of vascular endothelial growth factor (VEGF)-A may restore the integrity of the inner blood-retinal ...

Antivascular endothelial growth factor (VEGF) agents, including ranibizumab, aflibercept and bevacizumab, are currently the ... Images from a patient with no response to antivascular endothelial growth factor monotherapy who was treated with combined ... Images from a patient with no response to antivascular endothelial growth factor monotherapy who was treated with combined ...

Aims To provide data on plasma vascular endothelial growth factor (VEGF) concentration during three consecutive monthly ... Recovery of plasma vascular endothelial growth factor concentrations during aflibercept loading phase and after the transition ... Recovery of plasma vascular endothelial growth factor concentrations during aflibercept loading phase and after the transition ...

Factors influencing aqueous proinflammatory cytokines and growth factors in uveitic glaucoma. PLoS One 2016;11:e147080.doi: ... Relative corneal endothelial loss compared with the other eye was defined as the ratio of the number of corneal endothelial ... Peripheral vascular endothelial dysfunction in Glaucomatocyclitic crisis: a preliminary study. Invest. Ophthalmol. Vis. Sci. ... Clinical data, including peak IOP, visual acuity, corneal endothelial cell density, KPs, Tyndall effect and vertical cup-disc ...

For treatment of macular oedema secondary to retinal vein occlusion, anti-vascular endothelial growth factor therapy can result ... A new type of specular microscope enabled observation of a wide range of corneal endothelial layers in vivo and comparison of ...

... randomised to pegaptanib 0.3 mg or sham injections continuously in the first 2 years of the Vascular endothelial growth factor ...

... exogenous insulin could act synergistically with the vascular endothelial growth factor expressed by ischaemic retina so as to ... Risk factors for inclusion were either identified previously as risk factors in the literature or on the basis of their ... The risk factors identified in our models are unable to fully explain the risk of incidence and progression of DR. Several ... UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. ...

With the introduction of vascular endothelial growth factor inhibitors (anti-VEGF), the management of clinically significant ... such as evaluation of possible predictor factors for necessity of bevacizumab retreatment after navigated laser. ...

Transforming growth factor β isoforms in human optic nerve heads (1 February, 1999) Free Janethe D O Pena, Andrew W Taylor, ... Confocal microscopy in cornea guttata and Fuchs endothelial dystrophy (1 February, 1999) Free Auguste G-Y Chiou, Stephen C ... The healing optic nerve in glaucoma: transforming growth factor β and optic nerve head remodelling (1 February, 1999) Free M F ...